In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group
Published in: Chest
Date of publication: May 1, 1994
Language: English
Main subject: chronic obstructive pulmonary disease, multicenter clinical trial
Bibliographic databases:
Cites articles
There is nothing here
Article -